1978
DOI: 10.1021/bi00604a013
|View full text |Cite
|
Sign up to set email alerts
|

Cooperativity in ligand binding to dihydrofolate reductase

Abstract: 2,4-Diaminopyrimidine and p-aminobenzoyl-L-glutamate can be regarded as "fragments" of methotrexate, a potent inhibitor of dihydrofolate reductase. The equilibrium constants for the binding of these "fragments" and of a series of structurally related compounds to Lactobacillus casei dihydrofolate reductase have been determined by fluorimetric methods. 2,4-Diaminopyrimidine and p-aminobenzoyl-Lglutamate bind cooperatively to the enzyme, in the sense that p-aminobenzoyl-L-glutamate binds 54-fold more tightly to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

14
71
0

Year Published

1978
1978
2002
2002

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(85 citation statements)
references
References 18 publications
14
71
0
Order By: Relevance
“…This result implies that these compounds may interact with different but contiguous or partially overlapping subdomains of the same pharmacophore of an allosteric site. This finding is reminiscent of the simultaneous binding of 2,4-diaminopyrimidine and p-aminobenzoyl-glutamate (subcomponent moieties of methotrexate) to dihydrofolate reductase and their allosteric interactions with coenzyme analogs (Birdsall et al, 1978(Birdsall et al, , 1980. It has generally been assumed that muscarinic ligands that bind to the primary or, especially, allosteric site should have a basic nitrogen, although a few uncharged competitive antagonists ('carbo' analogs) have been described previously (Barlow and Tubby, 1974;Waelbroeck et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…This result implies that these compounds may interact with different but contiguous or partially overlapping subdomains of the same pharmacophore of an allosteric site. This finding is reminiscent of the simultaneous binding of 2,4-diaminopyrimidine and p-aminobenzoyl-glutamate (subcomponent moieties of methotrexate) to dihydrofolate reductase and their allosteric interactions with coenzyme analogs (Birdsall et al, 1978(Birdsall et al, , 1980. It has generally been assumed that muscarinic ligands that bind to the primary or, especially, allosteric site should have a basic nitrogen, although a few uncharged competitive antagonists ('carbo' analogs) have been described previously (Barlow and Tubby, 1974;Waelbroeck et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…K,, is determined from the ratio of the Kd values for successive complexes, and is a measure of the interaction between these complexes. By convention, the Kd for the complex formed last is used as the numerator in these calculations, and a value for K,,,,<l indicates a negative interaction (Birdsall et al, 1978 and Calculated from k,,JKd, using the Kd for the L-G~u binary complex (l/K3) and the steady-state turnover number (kcat). Determined from the Kd for the L-G~u binary complex (l/K3) and the apparent second-order association rate constant determined…”
Section: L-glu Binding To the Gdh-nad' Complexmentioning
confidence: 99%
“…Fluorometric measurements of the binding of 2,4-diaminopyrimidine and p-aminobenzoyl-L-glutamate to Lactobacillus casei cells revealed that the two fragments bind the bacterial enzyme simultaneously and cooperatively (5,6). Moreover, a recent study concerning the in vitro evaluation of the antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum also suggested the simultaneous-inhibition hypothesis as a possible mechanism of potentiation (13).…”
mentioning
confidence: 96%
“…Dihydrofolate reductase (5,6,7,8-tetrahydrofolate: NADP+ oxidoreductase; EC 1.5.1.3), which catalyzes the NADPH-dependent reduction of dihydrofolate to tetrahydrofolate, has been regarded as one of the crucial targets for bacterial and protozoal chemotherapy. The enzyme was shown to be the molecular site of action of a number of antifolates (2,8,32).…”
mentioning
confidence: 99%